Sophia Genetics has taken a new approach to the development and clinical adoption of Data Driven Medicine. Its AI platformprocesses and analyses raw genomic data to help hospitals better and faster diagnose patients. Their data analysis is concentrated in oncology, metabolism, paediatrics, cardiology, and hereditary cancer.
Sophia Genetics has a trio of co-founders who are recognized experts in the field of genetics, bioinformatics and molecular biology. Together, they have built a team of highly qualified PhDs from the top 10 Universities in the world. In just three years, Sophia Genetics has developed bioinformatics pipelines and visualization tools for more than 70 commercial panels, proprietary custom panels and is extending that capability to whole exomes and genomes. The company obtains CE-IVD marking for each supported pipeline and has received ISO 13485 certification.